|
|
TTD Drug ID:
DAP000666
Drug
Information |
Name | Piperazine | Synonyms | NCIOpen2_005575; D00807; NCIOpen2_001151; NCIOpen2_005182; NCIOpen2_005200; PZE; 1,4-Diethylenediamine; 1,4-Diazacyclohexane; Diethylenediamine; LTBB000432; Anthalazine; EINECS 203-808-3; 1951-97-9 (unspecified phosphate); P45907_SIAL; NCIOpen2_004982; NCIOpen2_004862; UN2579; Piperazin [German]; ARONIS23910; Worm-A-Ton; Spectrum_001113; Pyrazine, hexahy; 110-85-0; P0447; Wurmirazin; NCIOpen2_004952; NCIOpen2_005108; 80621_FLUKA; BIDD:GT0273; NCIOpen2_004914; IDI1_000038; NCIOpen2_004904; NCIOpen2_004874; Spectrum5_001817; Hexahydropyrazine; NCIOpen2_001231; NCIOpen2_005980; CCRIS 5950; NCIOpen2_001033; 8017-90-1; KBio2_006729; HMS2092A03; Vermex; Dispermine; NCIOpen2_004834; 16832-43-2 (unspecified hydrate); Pyrazine, hexahydro-; NCIOpen2_000984; Lumbrical; CHEBI:28568; NCIOpen2_005145; nchembio814-comp12; NINDS_000038; DivK1c_000038; NCIOpen2_001073; C07973; HSDB 1093; KBio2_001593; NCIOpen2_000988; InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H; Piperazine anhydrous; NCIOpen2_004830; Pipersol; 5-23-01-00030 (Beilstein Handbook Reference); Piperazine, anhydrous; Jsp000824; Eraverm; KBioSS_001593; NSC 474; Piperazin [Germany]; 14538-56-8 (phosphate[1:1]); P0446; NCIOpen2_004954; AR-1L1009; 854880-15-2; NCIOpen2_005072; AC1Q1IA7; NCGC00094762-02; Piperazine [UN2579] [Corrosive]; Piperazine [USAN]; BRN 0102555; DB00592; Pyrazine hexahydride; KBio2_004161; NCIOpen2_005034; Piperazine Hexa-Hydrate; 142-63-2 (hexahydrate); 1,4-Diazacyclohexane; UNII-1RTM4PAL0V; NCIOpen2_004994; KBio1_000038; Asca-Trol No. 3; 8057-14-5 (unspecified salt); NCIOpen2_001269; NCIOpen2_001111; Worm-away; NCIOpen2_001262; HMS500B20; Vermizine (TN); Eraverm (VAN); PIPERAZINE (HEXAHYDRATE); CID4837; NCIOpen2_005102; Piperazine [UN2579] [Corrosive]; 8027-81-4; MolPort-000-872-010; AKOS000269028; dro-; piperazinium oleate; LS-517; NCIOpen2_005187; SPECTRUM1500490; NCIOpen2_005062; NCIOpen2_001031; 1,4-Piperazine; Uvilon; NCIOpen2_001024; AC1Q1IA9; piperazine; AC1L1J2E; NCGC00094762-01; NCIOpen2_004942; Upixon; 7542-23-6 (mono-hydrochloride); Piperazine Dihydrochloride Dihydrochloride Hydrate; NCIOpen2_005022; 6094-40-2 (unspecified hydrochloride); AB1003720; I14-11172; Hexahydro-1,4-diazine; NCIOpen2_001071; HMS1920H20; 3597-26-0 (unspecified sulfate); NCIOpen2_004910; WLN: T6M DMTJ; 142-64-3 (di-hydrochloride); Piperazidine; NCIOpen2_005032; AC1Q1IA8; CHEMBL1412; Diethylenediamine; Antiren; NCIOpen2_005185; Diethyleneimine; Vermizine; NCIOpen2_004992; NCIOpen2_009422; Piperazin; Piperazine (USP); NSC474; 14007-05-7 (unspecified hydrobromide); 861800-35-3 | Indication | Ascariasis and enterobiasis [ICD9: 127.0, 127.4 ICD10: B77, B80] | Approved [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2 | InChIKey | GLUUGHFHXGJENI-UHFFFAOYSA-N | Canonical SMILES | C1CNCCN1 | Therapeutic Class | Antinematodal Agents | CAS Number | CAS 110-85-0 | Formula | C4H10N2 | PubChem Compound ID | CID 4837. | PubChem Substance ID | SID 10174. | ChEBI | 28568; | SuperDrug ATC ID | P02CB01 | SuperDrug CAS ID | 000054911; | Target | Gamma-aminobutyric acid receptor |  | Antagonist | [2] | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 080671 To Reference | Ref 2 | Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003 Sep;22(3):318-31. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|